Notice Type
Departmental
Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Sodium chloride 0.9 g per 100 mL in 10 mL, 20 mL Solution, infusion, ampoule B Braun Pharmaceutical Industries Snd Bhd, Bayan Lepas, Penang, Malaysia 0.9% Sodium Chloride Sodium chloride 0.9 g per 100 mL in 250 mL, 500 mL, 1000 mL Solution, infusion, bottle B Braun Pharmaceutical Industries Snd Bhd, Bayan Lepas, Penang, Malaysia 0.9% Sodium Chloride Dextrose monohydrate 5.0 g, sodium chloride 0.9 g per 100 mL in 500 mL, 1000 mL Solution, infusion, bottle B Braun Pharmaceutical Industries Snd Bhd, Bayan Lepas, Penang, Malaysia 0.9% Sodium Chloride & 5% Glucose Injection Dextrose monohydrate 5.0 g, per 100 mL in 100 mL, 250 mL, 500 mL, 1000 mL Solution, infusion, bottle B Braun Pharmaceutical Industries Snd Bhd, Bayan Lepas, Penang, Malaysia 5% Glucose Intravenous Infusion Amoxycillin trihydrate 500 mg, clavulanate potassium 125 mg Tablet Lek Pharmaceutical & Chemical Co., Ljubljana, Slovenia Amoxyclav Day-time component: Dextromethorphan hydrobromide 10 mg/5 mL, pseudoephedrine hydrochloride 30 mg/5 mL in 100 mL. Night-time component: Dextromethorphan hydrobromide 10 mg/5 mL, diphenhydramine hydrochloride 12.5 mg/5 mL, pseudoephedrine hydrochloride 30 mg/5 mL in 100 mL Syrup Parke-Davis Pty Limited, Caringbah, New South Wales, Australia Benadryl Day & Night Bupivacaine hydrochloride anhydrous equivalent to 0.25% w/v, 0.5% w/v bupivacaine hydrochloride Injection, solution, ampoule Antigen Pharmaceuticals Limited, Roscrea, Co Tipperary, Ireland Bupivacaine Hydrochloride Potassium chloride 0.27 g, sodium chloride 0.4 g, sodium lactate 0.58 g per 100 mL in 500 mL, 1000 mL Solution, infusion, bottle B Braun Pharmaceutical Industries Snd Bhd, Bayan Lepas, Penang, Malaysia Darrow's Solution Doxylamine succinate 25 mg Capsule R P Scherer Holdings Pty Limited, Braeside, Victoria, Australia Dozile Component 1: oestradiol 2 mg Component 2: oestradiol 2 mg, dydrogesterone 10 mg Tablets Solvay Duphar bv., Olst, The Netherlands Femoston 2/10 Calcium chloride dihydrate 0.027 g, potassium chloride 0.04 g, sodium chloride 0.6 g, sodium lactate 0.312 g per 100 mL in 500 mL, 1000 mL Solution, infusion, bottle B Braun Pharmaceutical Industries Snd Bhd, Bayan Lepas, Penang, Malaysia Hartmann's Solution 100IU, 400IU Hepatitis B immunoglobulin in a 16% w/v solution of IgG Injection, solution, vial C S L Limited, Broadmeadows, Victoria, Australia Hepatitis B Immunoglobulin 625IU (125 mcg) Rh (D) immunoglobulin per mL in a 16% w/v solution of IgG Injection, solution, vial C S L Limited, Broadmeadows, Victoria, Australia Rh (D) Immunoglobulin 250IU Tetanus antitoxin in a 16% w/v solution of IgG Injection, solution, vial C S L Limited, Broadmeadows, Victoria, Australia Tetanus Immunoglobulin Water for injection in 500 mL, 1000 mL Injection, bottle B Braun Pharmaceutical Industries Snd Bhd, Bayan Lepas, Penang, Malaysia Water for Injection 200IU Zoster immunoglobulin (human) per 2 mL in a 16% w/v solution of IgG Injection, solution, ampoule C S L Limited, Broadmeadows, Victoria, Australia Zoster Immunoglobulin (Human) Dated this 18th day of March 1997. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
Publication Date
27 Mar 1997

Notice Number

1997-go1765

Page Number

706